Mirabegron
NDC 70771-1752, Mirabegron, tablet, extended release, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1752
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209488
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1752 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIRABEGRON25 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1752-1 | 70771175201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-1) |
| 70771-1752-3 | 70771175203 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-3) |
| 70771-1752-9 | 70771175209 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/461b2b94-205a-4860-9cb4-d30267ada9df
Use it
Look up 70771-1752 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1752 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1752. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.